This website is in beta version
Projects
ESC Atlas of Cardiology
ESC Atlas in Heart Failure
ESC Atlas in Interventional Cardiology
Burden of Cardiovascular Disease
Countries
Data
National sociodemographic characteristics
Economic and health expenditure
Risk factors
Cardiovascular disease morbidity
Cardiovascular disease mortality
Cardiovascular healthcare delivery
Publications
About
Contact
MENU
Cardiovascular healthcare delivery data variables
Click on the category to get a list of all variables within that category
No results found.
Cardiological specialists
Cardiac surgeons (per million people)
Cardiologists (total) (per million people)
Cardiologists, females (% of cardiologists, total)
Interventional cardiologists (per million people)
Diagnostic coronary angiography
Coronary angiography and diagnostic cardiac catheterization (per million people)
Electrophysiology
Ablations to correct heart rhythm disorders (per million people)
Cardiac resynchronization therapy device (CRT-D and CRT-P) implantations (per million people)
Hospitals implanting cardiac resynchronization therapy (CRT) devices (per million people)
Hospitals implanting cardioverter defibrillators (ICDs) (per million people)
Hospitals implanting pacemakers (per million people)
Hospitals undertaking electrophysiology procedures (per million people)
Implantable cardioverter defibrillator (ICD) implantations (per million people)
Pacemaker implantations (per million people)
Interventional cardiology infrastructure
Hospital with cath labs (per million people)
Hospitals with cath labs and on-site cardiac surgery (per million people)
Hospitals with cath labs on 24 hours/7 days service (per million people)
Hospitals with cath labs performing TAVI (per million people)
Hospitals with cath labs performing structural heart disease interventions in children (per million people)
Hospitals with cath labs performing structural heart disease interventions in the adult (per million people)
Total cath labs (per million people)
Interventional cardiology procedures
Adjunctive intracoronary imaging techniques (per million people)
Adjunctive intracoronary physiology measurements (per million people)
Alcohol septum ablations (per million people)
Aortic balloon valvuloplasties (per million people)
Atrial septum closures (per million people)
Coronary bio-resorbable vascular scaffolds (per million people)
Coronary drug-eluting stents (per million people)
Coronary stents (per million people)
Left atrial appendage occlusions (per million people)
Mitral balloon valvuloplasties (per million people)
Percent of percutaneous coronary interventions (PCI) performed by trans-radial access
Percutaneous aortic valve implantation (TAVI) (per million people)
Percutaneous coronary interventions (PCI) (per million people)
Percutaneous coronary interventions (PCI) for in-stent restenosis (per million people)
Percutaneous coronary interventions (PCI) in coronary artery with chronic total occlusions (CTO) (per million people)
Percutaneous coronary interventions (PCI) in unprotected left main (LM) coronary artery (per million people)
Percutaneous coronary interventions (PCI) performed with adjunctive intracoronary imaging techniques (per million people)
Percutaneous coronary interventions (PCI) performed with adjunctive intracoronary physiology measurements (per million people)
Percutaneous coronary interventions (PCI) with drug-eluting balloons (per million people)
Percutaneous coronary interventions (PCI) with rotational or orbital atherectomy (per million people)
Percutaneous coronary interventions (PCI) without stent (per million people)
Percutaneous mitral valve interventions (per million people)
Percutaneous tricuspid valve interventions (per million people)
Peri-valvular leaks closures (per million people)
Primary percutaneous coronary intervention (pPCI) (per million people)
Procedures with cerebral embolic protection devices (per million people)
Use of hemodynamic support devices (per million people)
Valve-in-valve percutaneous implantations (per million people)
Ventricular septum closures (per million people)
Heart failure health care
Average length of stay in hospital primarily due to HF
Cardiac MRI units (per million people)
Cardiology departments performing device-based decongestion therapy (per million people)
Hospitals implanting Mitraclip (per million people)
Hospitals implanting left ventricular assist devices (LVAD) (per million people)
Hospitals performing HF exercise programs for HF patients (per million people)
Hospitals performing spiro-ergometry (per million people)
Hospitals with advanced ultrasound imaging (per million people)
Hospitals with availability to obtain BNP (NT-proBNP) in ER (per million people)
Hospitals with dedicated HF centers (per million people)
Number of HF-related hospital discharges (per million people)
Palliative care units for patients with advanced/end-stage HF (per million people)
Cardiac surgery
Heart transplantations (per million people)
Left, right and both ventricular assist device implantations (per million people)
Surgical interventions in congenital heart disease (per million people)
Congenital heart disease
Hospitals undertaking congenital heart disease surgery (per million people)
Percutaneous procedures for congenital heart disease (per million people)
Cardiac Capital Resources
Hospitals with cardiac rehabilitation programmes (per million people)
Hospitals with dedicated coronary care units (per million people)
Hospitals with dedicated stroke units (per million people)